Develops cell therapies for knee cartilage and burn injuries.
Jun 2026Revenue $306M/yrExpenses $288M/yr
No trend
Figures by year
Is Vericel profitable?
Yes. In the 12 months to Jun 2026, revenue was $306M and expenses $288M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $276M | $265M | $11.0M |
| Dec 2024 | $237M | $233M | $4.52M |
| Dec 2023 | $198M | $204M | −$6.46M |
| Dec 2022 | $164M | $181M | −$17.1M |
| Dec 2021 | $156M | $164M | −$7.85M |
| Dec 2020 | $124M | $122M | $2.37M |
| Dec 2019 | $118M | $129M | −$11.3M |
| Dec 2018 | $90.9M | $94.8M | −$3.91M |
| Dec 2017 | $63.9M | $78.9M | −$15.0M |
| Dec 2016 | $54.4M | $73.6M | −$19.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.